Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation

Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation

Background/AimsThe dose of mycophenolate mofetil (MMF) has been reduced in Asia due to side effects associated with the conventional fixed dose of 2-3 g/day. We aimed to determine the pharmacokinetics of a reduced dose of MMF and to validate its feasibility in combination with tacrolimus in living-d...

Full description

Bibliographic Details
Main Authors: Hyeyoung Kim, Nam-Joon Yi, Juyeun Lee, Joohyun Kim, Mi-Ra Moon, Jaehong Jeong, Jeong-Moo Lee, Tae Suk You, Suk-Won Suh, Min-Su Park, YoungRok Choi, Geun Hong, Hae Won Lee, Kwang-Woong Lee, Kyung-Suk Suh
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2014-09-01
Series:Clinical and Molecular Hepatology
Subjects:
Area under the curve
Mycophenolate mofeti
Mycophenolic acid
Therapeutic drug monitoring
Liver transplant
Online Access:http://e-cmh.org/upload/pdf/cmh-20-291.pdf

Internet

http://e-cmh.org/upload/pdf/cmh-20-291.pdf

Similar Items